Orpha Labs AG Initiates Compassionate Use Program for ORL-101 in Leukocyte Adhesion Deficiency Type II (LAD-II)
First Patient to Receive ORL-101 in Israel This Week Canada NewsWire BAAR, Switzerland,Feb. 8, 2021/CNW/ — Orpha Labs AG today
Read moreFirst Patient to Receive ORL-101 in Israel This Week Canada NewsWire BAAR, Switzerland,Feb. 8, 2021/CNW/ — Orpha Labs AG today
Read moreCropLife Asia Statement: Reaction to New UN Regional Report on State of Food Security and Nutrition in Asia SINGAPORE, Jan
Read moreUltrack Systems (MJLB) Expands Worldwide Through Iridium Satellite (IRDM) and Kore Wireless Contract Concord, Ontario–(Newsfile Corp. – January 11, 2021)
Read moreFACT Positioned to be Global Innovator in Fine Art and Collectible Authentication and Security Toronto, Ontario–(Newsfile Corp. – January 7,
Read more